★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★Open research. Global perspectives.
Medical Sciences OPEN ACCESS

inical And Laboratory Results Of Intrauterine Device Cu T 380 A Intrauterine System Intraoperative Injection

Nasirova Zebiniso Azizovna
Samarkand State Medical Institute, Samarkand, Uzbekistan
Negmadjanov Bahodur Boltaevich
Samarkand State Medical Institute, Samarkand, Uzbekistan
tajmspr 2020
VOL. 2 / NO. 09 SEPTEMBER
VOLUME 2
ISSUE 09
YEAR 2020
PAGES 89-95

Abstract

Effective and safe contraceptive methods not only prevent unplanned pregnancies and their
termination, but also make it possible to fully restore the mother's body after surgery to carry out the
necessary pre-pregnancy preparation. The goal of the study was to evaluate the clinical outcome of
postplacental administration of Cu T 380 A in women during a caesarean section. The study was
conducted at Samarkand Maternity Hospital No. 2 to assess the clinical outcome of postplacental
administration of Cu T 380 A in women during caesarean section. The present study showed that there
were no serious complications and only minor side effects such as pain, fever, bleeding and irregular
bleeding, which were observed only in some women during the hospital stay and the control visit in
the first 6 months. The determination of vaginal BMW tendrils was made possible in 72.12% of women
during the control visit after 6 weeks. The visibility of the tendrils increased over time and after 6
months they were seen in 90.81% of cases. Exposure frequency was 2 cases (4%) and another 2 women
(4%) required removal of the PMTCT for various reasons, resulting in a 92.3% retention rate six months
after contraception. No cases of pregnancy were registered. Post-placental introduction of BIC Cu T
380 A during a C-section is a practical, convenient, safe, effective and acceptable contraceptive
method.

Keywords

Сlinical results, BIC Cu T 380 A

Downloads

Download data is not yet available.

References

  1. An A.V., Pakhomova J.E., Maternal lethality
  2. after Caesarean section. Problems of
  3. Reproduction No. 3, 2010; pp.83-86.
  4. Ayupova F.M., Khamdamova M.T. Clinical
  5. aspects of the use of copper-containing
  6. intrauterine devices // Uzbekiston Tibbiet
  7. Journalist. -2010. № 6. 59-64.
  8. Dikke G.B. LARC-methods of first choice in
  9. prevention of unwanted pregnancy and
  10. repeated abortion // Pharmatek. 2013. №.
  11. p. 8-13.
  12. Barbosa RM, et al. Differences in the
  13. Access to Sterilization between Women
  14. Living and Not Living with HIV: Results
  15. from the GENIH Study, Brazil PLoS One
  16. Brunson M. R. et al. Postpartum
  17. contraception: and effectiveness in a large
  18. universal healthcare system //American
  19. journal of obstetrics and gynecology. 2017.
  20. Т. 217. №. 1. Pp. 55. e1-55. e9.
  21. Garcia G. et al. Trends and disparities in
  22. postpartum sterilization after cesarean
  23. section, 2000 through 2008 //Women's
  24. Health Issues. 2015. Т. 25. №. 6. p. 634-640.
  25. Goldthwaite LM, et al. Postpartum
  26. intrauterine devices: clinical and
  27. programmatic review Am J Obstet Gynecol
  28. - Review.
  29. Haider S. et al. A Novel Approach to
  30. Postpartum Contraception Provision
  31. Combined with Infant Care: A Randomized,
  32. Controlled Trial //Women's Health Issues.
  33. Т. 30. №. 2. p. 83-92
CONTINUE EXPLORING

Most read articles by the same author(s)

Explore other published research by the authors of this article.